Conditions We Treat
The conditions for which we provide Hyperbaric Oxygen Therapy (HBOT) fall into two categories: emergency and elective.
Referrals and Funding – Commissioning Statement
Important Commissioning Information For Clinicians and Patients from 2019 Onwards.
LHM Healthcare is pleased to confirm that we are being funded by NHS England to provide a Pan-London emergency hyperbaric service at Whipps Cross University Hospital to cover the whole of London and southeast England.
We will also be providing a Hyperbaric emergency service for the East of England region from our Unit at the James Paget University Hospital in Great Yarmouth.
In July 2018 NHS England published several new Commissioning Policies for HBOT and has confirmed routine funding for the following two emergency conditions:
NHS England has recently decided to withdraw routine funding for all other emergency and elective indications but strongly supports research and the collection of strong clinical evidence.
This will be achieved by providing treatments on an evaluative research basis and collecting clinical data using registries. These treatments will however no longer be funded by NHS England.
LHM Healthcare will continue to accept and treat NHS patients on an evaluative/ research basis for those conditions, which NHSE has previously funded and which align most closely with the principles of evidence-based medicine.
- Late radiation tissue injury – Treatment and prophylaxis of osteoradionecrosis)
- Late radiation tissue injury – Treatment and prophylaxis of radionecrosis of soft tissue.
- Selected Problem Wounds (eg. compromised grafts and flaps, diabetic foot ulcers, Hypoxic wounds etc.)
Treatment for these and other selected elective conditions will usually be provided at no cost to the patient by LHM Healthcare for NHS patients who are referred to us by NHS clinicians using established care pathways, and at the discretion of our team. Patients will be asked to enrol in our NHS-approved evaluative treatment program and make a voluntary donation to our research fund.
